NOOTROPIC ACTIVITY OF A NOVEL (-)-CYTISINE DERIVATIVE (3AR,4S,8S,12R, 12AS,12BR)-10-METHYL-2-PHENYLOCTAHYDRO-1H-4,12A-ETHENO-8,12-METHANOPYRROLO[3’,4’:3,4]PYRIDO[1,2-A] [1,5]DIAZOCINE-1,3,5(4H)-TRIONE Makara, N.S.,
Sapozhnikova, T.A.,
Khisamutdinova, R.Y.,
Tsypysheva, I.P.,
Borisevich, S.S.,
Kovalskaya, A.V.,
Petrova, P.R.,
Khursan, C.L.,
Zarudii, F.S. (2018) conditions (
3aR,4S,8S,12R,12aS,12bR)-10-methyl-2-phenyloctahydro-1H-4,12a-etheno-8,12-methanopyrrolo[
3’,4’:3A series of 8-amino-substituted 1-butyl-
3-methylxanthines containing a thietane ring were obtained
ZAGIDULLIN, N.SH.,
HAMITOVA, A.,
LAKMAN, I.,
KRIONI, I.,
GAREEVA, D.,
ZULKARNEEV, R.,
TULBAEV, E. (2020) The biomarkes NT-proBNP, ST2 and Pentraxin-
3 (Ptx-
3) have emerged as potential powerful tools
8-Bromo-1-iso-butyl-
3-methyl-7-(thietanyl-
3)xanthine (II) was synthesized by alkylation of 8-bromo
Motloch, L.J.,
Larbig, R.,
Darabi, T.,
Reda, S.,
Motloch, K.A.,
Wernly, B.,
Lichtenauer, M.,
Gebing, T.,
Schwaiger, A.,
Zagidullin, N.,
Wolny, M.,
Hoppe, U.C. (2017) Background Caveolin-
3 (cav-
3) mutations are linked to the long-QT syndrome (LQTS) causing distinct
Gurevich, KG,
Urakov, AL,
Rozit, GA,
Klen, EE,
Samorodov, AV,
Khaliullin, FA (2021) Sulfone II was synthesized via oxidation of ethyl 2-[5-bromo-2,4-dihydro-
3-oxo-2-(thietanyl-
3